SYS-CON MEDIA Authors: Kevin Benedict, Gilad Parann-Nissany, Michael Bushong, Eric Brown

News Feed Item

Bayport Medicinal Research, Inc., a Wholly Owned Subsidiary of Bayport International Holdings, Inc., (BAYP) Is Pleased to Announce "Another" New Product Addition

TULSA, OK -- (Marketwired) -- 05/30/14 -- Bayport Medicinal Research, Inc., a wholly owned subsidiary of Bayport International Holdings, Inc., (OTC Pink: BAYP) (PINKSHEETS: BAYP) is pleased to announce that the third product in its line of new skin care products has now been formulated and the labeling is now complete. The first, a hand and body lotion, the second, a non-surgical facelift and the third is a new deep tissue muscle roll-on. It is anticipated that mass production will commence in the next few weeks and these three products will be available for purchase very soon thereafter.

Bayport Medicinal Research, Inc. will begin to manufacture and produce for distribution their fourth item, a body moisturizer, currently in the works. Final adjustments to our exclusive formula are nearing completion and labeling is complete.

Bayport will continue to add dynamic new products as research dictates. We are currently investigating the legal ramifications of adding hemp oil and cannabidiol CBD to current and future products and will keep our shareholders up to date on our progress.

Bayport is actively and aggressively exploring distributorships and further means of marketing products. Bayport has engage several finance companies which share Bayport's vision of growth and excitement to bring such products to mass production and distribution worldwide.

Bayport Medicinal Research, Inc. is actively building our e-commerce website database at: www.bayportmedicinal.com. Bayport International Holdings will also include a link on its website for the purchase of these products.

Bayport Medicinal Research, Inc. would like to invite investors and consumers to try a free sample of our brand new Ultra Shield skin cream with Aloe Vera. Samples will be ready for distribution within 30 business days or sooner. For a free sample, while supplies last, contact:

Disclaimer: Pacific Equity Alliance, LLC. is an Independent Investor Relations firm that provides information on selected publicly trade d companies. Pacific Equity Alliance, LLC. is not a United States Securities Dealer or Broker or United States registered Investment Adviser. This email letter and any and all attachments and related documents are never considered to be solicitation for any purpose in any form or content. Pacific Equity Alliance, LLC.'s Affiliates, Officers, Directors and Employees will buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own due diligence before investing in any of the stocks mentioned above. Upon receipt of these documents you, as the Recipient, hereby acknowledge this Warning and Disclaimer. These Confidential communications are protected under Gramm-Leach-Bailey Act 15 USC, Sub chapter 1, sections 6801-6809 and other laws addressing the disclosure of Non-Public Personal Information.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.